Taylor & Francis Group
Browse
iwbp_a_1386324_sm1606.doc (505.5 kB)

Genetic analysis for cognitive flexibility in the trail-making test in attention deficit hyperactivity disorder patients from single nucleotide polymorphism, gene to pathway level

Download (505.5 kB)
Version 3 2019-09-17, 11:04
Version 2 2017-10-25, 10:17
Version 1 2017-10-03, 10:08
journal contribution
posted on 2019-09-17, 11:04 authored by Kunlin Zhang, Zili Fan, Yufeng Wang, Stephen V. Faraone, Li Yang, Suhua Chang

Objectives: Investigation of the genetic basis of endophenotype and analysis the pathways with multiple genes of small effects might increase the understanding of the genetic basis of attention deficit hyperactivity disorder (ADHD). Here we aimed to explore the genetic basis of cognitive flexibility in ADHD at the single nucleotide polymorphism (SNP), gene and pathway levels.

Methods: The trail-making test was used to test the cognitive flexibility of 788 ADHD patients. A genome-wide association analysis of cognitive flexibility was conducted for 644,166 SNPs.

Results: The top SNP rs2049161 (P = 5.08e-7) involved gene DLGAP1 and the top gene CADPS2 in the gene-based analysis resulted in much literature evidence of associations with psychiatric disorders. Gene expression and network analysis showed their contribution to cognition function. The interval-enrichment analysis highlighted a potential contribution of ‘adenylate cyclase activity’ and ADCY2 to cognitive flexibility. Candidate pathway-based analysis for all SNPs found that glutamate system-, neurite outgrowth- and noradrenergic system-related pathways were significantly associated with cognitive flexibility (FDR <0.05), among which the neurite outgrowth pathway was also associated with ADHD symptoms.

Conclusions: This study provides evidence for the genes and pathways associated with cognitive flexibility and facilitate the uncovering of the genetic basis of ADHD.

Funding

This work was supported by the Major State Basic Research Development Program of China [grant number 2014CB846104]; the National Natural Science Foundation of China [grant numbers 31401139, 81471381, 81101545 and 31470070]; Beijing Municipal Science & Technology Commission [grant number Z151100003915122]; Sanming Project of Medicine in ShenZhen [(2017)28-44] to Shenzhen Children's Hospital and ADHD research group from Peking University Sixth Hospital; the CAS Key Laboratory of Mental Health, Institute of Psychology; the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; the European Union’s Seventh Framework Programme for research, technological development and demonstration [grant number 602805]; the European Union’s Horizon 2020 research and innovation programme [grant number 667302]; NIMH [grant numbers 5R01MH101519 and U01 MH109536-01].

History